Studies on the role of osteopontin-1 in endometrial cancer cell lines

Strahlentherapie und Onkologie

Volumn 189, Issue 12, 2013, Pages 1040-1048

  Hahne, J C ^a   Meyer, S R ^a   Kranke, P ^a   Dietl, J ^a   Guckenberger, M ^a   Polat, B ^a   Honig A ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Endometrial neoplasms; Neoplasm metastasis; Osteopontin 1; Radiation therapy; RNA, small interfering

Indexed keywords

BETA ACTIN; CASPASE 3; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OSTEOPONTIN; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLONOGENESIS; CONTROLLED STUDY; DENSITOMETRY; ENDOMETRIUM CANCER; ENDOMETRIUM CELL; FEMALE; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR INVASION; WESTERN BLOTTING; WOUND HEALING; ENDOMETRIAL NEOPLASMS; GENE EXPRESSION REGULATION; METABOLISM; RADIATION DOSE; RADIATION RESPONSE; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OSTEOPONTIN; RADIATION DOSAGE;

EID: 84890963921     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-013-0434-y     Document Type: Article

References (33)

1. Bakkum-Gamez JN, Gonzales-Bosquet J, Laack NN et al (2008) Current issues in the management of endometrial cancer. Mayo Clin Proc 83:97-112
2. Bottke D, Wiegel T, Kreienberg R et al (2007) Stage IB endometrial cancer. Does lymphadenectomy replace adjuvant radiotherapy? Strahlenther Onkol 183:600-604 (Pubitemid 350124277)
3. Chang SH, Minai-Tehrani A, Shin JY et al (2012) Beclin1-induced autophagy abrogates radioresistance of lung cancer cells by suppressing osteopontin. J Radiat Res 53:422-432
4. Djuzenova C, Mühl B, Schakowski R et al (2004) Normal expression of DNA repair proteins, hMre11, Rad50 and Rad51 but protracted formation of Rad50 containing foci in X-irradiated skin fibroblasts from radiosensitive cancer patients. Br J Cancer 90:2356-2363 (Pubitemid 38961900)
5. Du XL, Jiang T, Sheng XG et al (2009) Inhibition of osteopontin suppresses in vitro and in vivo angiogenesis in endometrial cancer. Gynecol Oncol 115:371-376
6. Erpolat OP, Gocun PU, Akmansu M et al (2013) Hypoxia-related molecules HIF-1?, CA9, and osteopontin. Strahlenther Onkol 189:147-154
7. Fisher LW, Fedarko NS (2003) Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect Tissue Res 44:33-40 (Pubitemid 36395419)
8. Hänsgen G, Nagel M, Dunst J, Enke H (1999) Postoperative radiotherapy in endometrial carcinoma. A retrospective analysis of 541 cases. Strahlenther Onkol 175:548-553 (Pubitemid 29529114)
9. Herbolsheimer M (1997) Radical lymph node excision in endometrial carcinoma: the restriction of pelvic irradiation to node-positive cases? Strahlenther Onkol 173:288-289
10. Hille A, Christiansen H, Pradier O et al (2005) Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis. Strahlenther Onkol 181:606-614 (Pubitemid 41346201)
11. Huguenin P, Baumert B, Lütolf UM et al (1999) Curative radiotherapy in elderly patients with endometrial cancer. Patterns of relapse, toxicity and quality of life. Strahlenther Onkol 175:309-314 (Pubitemid 29331049)
12. Karadag A, Ogbureke KUE, Fedarko NS, Fisher LW (2004) Bone sialoprotein, matrix metalloproteinase 2, and ?v?3 integrin in osteotropic cancer cell invasion. J Natl Cancer Inst 96:956-965 (Pubitemid 38868142)
13. Lin YH, Yang-Yen HF (2001) The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway. J Biol Chem 276:46024-46030
14. Makrydimas G, Zagorianakou N, Zagorianakou P, Agnantis NJ (2003) CD44 family and gynaecological cancer. In Vivo 17:633-640 (Pubitemid 38165466)
15. Micke O, Bruns F, Halek G et al (2003) Long-term results of postoperative radiotherapy for stage I endometrial carcinoma. Strahlenther Onkol 179:729-736 (Pubitemid 37376986)
16. Pötter R, Knocke TH (1998) Isolated vaginal recurrences in endometrial carcinoma: treatment results using high-dose-rate intracavitary brachytherapy and external beam radiotherapy. Strahlenther Onkol 174:488-489
17. Polat B, Wohlleben G, Katzer A et al (2013) Influence of osteopontin silencing on survival and migration of lung cancer cells. Strahlenther Onkol 189:62-67
18. Rae JM, Creighton CJ, Meck JM et al (2007) MDA-MB-435 cells are derived from M14 melanoma cells-a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res Treat 104:13-19 (Pubitemid 46976633)
19. Renner W, Atzinger A (1997) Value of adjuvant progestagen therapy in patients with endometrial carcinoma. Strahlenther Onkol 173:485-486
20. Rittling SR, Chambers AF (2004) Role of osteopontin in tumor progression. Br J Cancer 80:1877-1881
21. Salih E, Ashkar S, Gerstenfeld LC, Glimcher MJ (1997) Identification of the phosphorylated sites of metabolically 32P-labeled osteopontin from cultured chicken osteoblasts. J Biol Chem 272:13966-13973 (Pubitemid 27224842)
22. Senger DR, Perruzzi CA, Gracey CF et al (1988) Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation. Cancer Res 48:5770-5774
23. Senger DR, Perruzzi CA, Papadopoulus-Sergiou A, Water L van de (1994) Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain. Mol Biol Cell 5:565-574 (Pubitemid 24183445)
24. Shevde LA, Das S, Clark DW, Samant RS (2010) Osteopontin: an effector and an effect of tumor metastasis. Curr Mol Med 10:71-81
25. Shevde LA, Samant RS, Paik JC et al (2006) Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma MDA-MB-435. Clin Exp Metastasis 23:123-133 (Pubitemid 44440172)
26. Solberg TD, Nearman J, Mullins J et al (2008) Correlation between tumor growth delay and expression of cancer and host VEGF, VEGFR2, and osteopontin in response to radiotherapy. Int J Radiat Oncol Biol Phys 72:918-926
27. Toy H, Yavas O, Eren O et al (2009) Correlation between osteopontin protein expression and histological grade of astrocytomas. Pathol Oncol Res 15:203-207
28. Weber GF (2001) The metastatic gene osteopontin: a candidate target for cancer therapy. Biochim Biophys Acta 1552:61-85 (Pubitemid 34124131)
29. Weber GF, Ashkar S, Glimcher MJ, Cantor H (1996) Receptor ligand interaction between DC44 and osteopontin (Eta-1). Science 271:509-512
30. Weitmann HD, Knocke TH, Waldhäusl C, Pötter R (2006) Ultrasound-guided interstitial brachytherapy in the treatment of advanced vaginal recurrences from cervical and endometrial carcinoma. Strahlenther Onkol 182:86-95 (Pubitemid 43177193)
31. Zhang A, Liu Y, Shen Y et al (2010) Osteopontin silencing by small interfering RNA induces apoptosis and suppresses invasion in human renal carcinoma Caki-1 cell. Med Oncol 27:1179-1184
32. Zang LL, Shao SL, Wu Y (2010) Expression of osteopontin and B7-H4 in epithelial ovarian neoplasm and their significance. Chin J Cancer 29:25-29
33. Zohar R, Zhu B, Liu P et al (2004) Increased cell death in osteopontin-deficient cardiac fibroblasts occurs by a caspase-3-independent pathway. Am J Physiol Heart Circ Physiol 287:H1730-H1739 (Pubitemid 39313280)